drug · antibody
cadonilimab
Phase 2updated 3mo agoby Akeso Inc🔗 ChEMBL
Phase 2community read0 votes
🐶 often sniffed alongside
top 4Antibody drug with a maximum clinical stage of Phase 3 (across all indications), with 40 investigational indications.
targets
Programmed cell death protein 1Cytotoxic T-lymphocyte protein 4
all catalysts(1)
Trials studying cadonilimab
- phase2HAIC, Lenvatinib, and Cadonilimab as Conversion Therapy for Initially Unresectable Hepatocellular Carcinoma
- phase3Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma
- phase2Anlotinib+Cadonilimab+PULSAR in Advanced Biliary Tract Cancer
- phase3Neoadjuvant/Adjuvant AK104 in Microsatellite Instability-high or Mismatch Repair-deficient, Resectable Colon Cancer
- phase2AK112 and Cadonilimab Combined With Chemotherapy for 1L Treatment of Metastatic Pancreatic Cancer
- phase2A Study of AK112 in Patients With Advanced Hepatocellular Carcinoma (HCC)
- EP1THIO and Cadonilimab in Resectable Hepatocellular Carcinoma
- phase2Ligufalimab and Cadonilimab in Advanced Liver Cancers
News(0)
no news has mentioned this drug yet
Data sources
last refreshed just now
Found something off?
comments(0)
5-min edit window · permanent after that